Search research articles
Contact Us
Filters
Showing results (501-510 of 594) with videos related to
Page
of 60
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 30, 2019
Myoclonus-dystonia caused by GNB1 mutation responsive to deep brain stimulation
Hannah F Jones, Hugo Morales-Briceño, Katy Barwick, et al.
Genome Biology
|
February 5, 2015
Global mRNA selection mechanisms for translation initiation
Joseph Costello, Lydia M Castelli, William Rowe, et al.
Plos One
|
March 19, 2015
Dystrophic spinal deformities in a neurofibromatosis type 1 murine model
Steven D Rhodes, Wei Zhang, Dalong Yang, et al.
Cancer Research
|
September 17, 2016
Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma
Linlin Xu, Khalid S Mohammad, Hao Wu, et al.
Molecular Cancer Research : MCR
|
April 24, 2012
Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis
Sirkku Pollari, Rami S Käkönen, Khalid S Mohammad, et al.
Heliyon
|
November 11, 2025
Retraction notice to "Evaluation of <i>Sechium edule</i> fruit attenuation impact on the cardiomyopathy of the STZ-induced diabetic rats" [Heliyon 10 (2024) e30440]
Firdous S Mohammad, Ujjaini Das, Samir K Samanta, et al.
Frontiers in Pharmacology
|
December 7, 2013
P-glycoprotein mediated efflux limits substrate and drug uptake in a preclinical brain metastases of breast cancer model
Chris E Adkins, Rajendar K Mittapalli, Vamshi K Manda, et al.
Annals of Clinical and Translational Neurology
|
February 19, 2026
Ketogenic Diet as an Epigenetic Therapy in SETD1B-Related Epilepsy
Erica Tsang, Brian S Gloss, Jessica P Hayes, et al.
Heliyon
|
May 14, 2024
Evaluation of <i>Sechium edule</i> fruit attenuation impact on the cardiomyopathy of the STZ-induced diabetic rats
Firdous S Mohammad, Ujjaini Das, Samir K Samanta, et al.
Immuno-Oncology Technology
|
May 2, 2024
Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: the phase I TRIBE trial
K S Shohdy, M Pillai, K S Abbas, et al.
Page
of 60
Search research articles
Search
Showing results (501-510 of 594) with videos related to
Sort By:
Page
of 60
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 30, 2019
Myoclonus-dystonia caused by GNB1 mutation responsive to deep brain stimulation
Hannah F Jones, Hugo Morales-Briceño, Katy Barwick, et al.
Genome Biology
|
February 5, 2015
Global mRNA selection mechanisms for translation initiation
Joseph Costello, Lydia M Castelli, William Rowe, et al.
Plos One
|
March 19, 2015
Dystrophic spinal deformities in a neurofibromatosis type 1 murine model
Steven D Rhodes, Wei Zhang, Dalong Yang, et al.
Cancer Research
|
September 17, 2016
Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma
Linlin Xu, Khalid S Mohammad, Hao Wu, et al.
Molecular Cancer Research : MCR
|
April 24, 2012
Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis
Sirkku Pollari, Rami S Käkönen, Khalid S Mohammad, et al.
Heliyon
|
November 11, 2025
Retraction notice to "Evaluation of <i>Sechium edule</i> fruit attenuation impact on the cardiomyopathy of the STZ-induced diabetic rats" [Heliyon 10 (2024) e30440]
Firdous S Mohammad, Ujjaini Das, Samir K Samanta, et al.
Frontiers in Pharmacology
|
December 7, 2013
P-glycoprotein mediated efflux limits substrate and drug uptake in a preclinical brain metastases of breast cancer model
Chris E Adkins, Rajendar K Mittapalli, Vamshi K Manda, et al.
Annals of Clinical and Translational Neurology
|
February 19, 2026
Ketogenic Diet as an Epigenetic Therapy in SETD1B-Related Epilepsy
Erica Tsang, Brian S Gloss, Jessica P Hayes, et al.
Heliyon
|
May 14, 2024
Evaluation of <i>Sechium edule</i> fruit attenuation impact on the cardiomyopathy of the STZ-induced diabetic rats
Firdous S Mohammad, Ujjaini Das, Samir K Samanta, et al.
Immuno-Oncology Technology
|
May 2, 2024
Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: the phase I TRIBE trial
K S Shohdy, M Pillai, K S Abbas, et al.
Page
of 60